Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

175 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomized, multicenter controlled trial to compare the efficacy of recombinant human parathyroid hormone (1-34) with elcatonin in postmenopausal women with osteoporosis in China.
Zhang XZ, Wang B, Yang J, Xuan M, Song LG, Li H, Guo XH, Lü XF, Xue QY, Yang GY, Ji QH, Shen J, Liu ZM, Li CJ, Wu TF, Tong XC, Jia Y. Zhang XZ, et al. Among authors: ji qh. Chin Med J (Engl). 2009 Dec 20;122(24):2933-8. Chin Med J (Engl). 2009. PMID: 20137477 Clinical Trial.
[A randomized, multicenter, active-controlled trial to compare the efficacy of recombinant human parathyroid hormone (1-34) with that of elcatonin in postmenopausal women with osteoporosis in China].
Zhang XZ, Song LG, Wang B, Yang J, Li H, Xuan M, Lei T, Guo XH, Lü XF, Xue QY, Yang GY, Ji QH, Shen J, Liu ZM, Li CJ, Wu TF, Xie HB, Tong JC. Zhang XZ, et al. Among authors: ji qh. Zhonghua Nei Ke Za Zhi. 2010 Aug;49(8):662-6. Zhonghua Nei Ke Za Zhi. 2010. PMID: 20979784 Clinical Trial. Chinese.
[The design and baseline characteristics of a phase III study to evaluate the efficacy and safety of alogliptin versus placebo in type 2 diabetes mellitus in Mainland China].
Pan CY, Li WH, Zeng JE, Li CJ, Yang JK, Ji QH, Lu JM, Lü XF, Li XF, Qu S, Xu XJ, Xue YM, Li L, Jiang ZS, Zheng BZ, Bu RF, Han P, Liu Y, Liu JD, Peng YD, Liu XM, Liu ZM, Yan L, Lei MX, Li XJ, Song QH, Shi BY, Gu W, Li ZF. Pan CY, et al. Among authors: ji qh. Zhonghua Nei Ke Za Zhi. 2013 Nov;52(11):932-5. Zhonghua Nei Ke Za Zhi. 2013. PMID: 24439186 Clinical Trial. Chinese.
[Efficacy and safety of Changsulin® compared with Lantus® in type 2 diabetes: a phase Ⅲ multicenter, randomized, open-label, parallel, controlled clinical trial].
Zhang TT, Liu XM, Shi BY, Wang CJ, Mo ZH, Liu Y, Shan ZY, Yang WY, Li QM, Lyu XF, Yang JK, Xue YM, Zhu DL, Shi YQ, Huang Q, Zhou ZG, Wang Q, Ji QH, Li YB, Gao X, Lu JM, Zhang JQ, Guo XH. Zhang TT, et al. Among authors: ji qh. Zhonghua Nei Ke Za Zhi. 2020 Dec 1;59(12):960-967. doi: 10.3760/cma.j.cn112138-20200423-00417. Zhonghua Nei Ke Za Zhi. 2020. PMID: 33256337 Clinical Trial. Chinese.
Glycemic control among patients in China with type 2 diabetes mellitus receiving oral drugs or injectables.
Ji LN, Lu JM, Guo XH, Yang WY, Weng JP, Jia WP, Zou DJ, Zhou ZG, Yu DM, Liu J, Shan ZY, Yang YZ, Hu RM, Zhu DL, Yang LY, Chen L, Zhao ZG, Li QF, Tian HM, Ji QH, Liu J, Ge JP, Shi LX, Xu YC. Ji LN, et al. Among authors: ji qh. BMC Public Health. 2013 Jun 21;13:602. doi: 10.1186/1471-2458-13-602. BMC Public Health. 2013. PMID: 23800082 Free PMC article.
Impact of waist circumference and body mass index on risk of cardiometabolic disorder and cardiovascular disease in Chinese adults: a national diabetes and metabolic disorders survey.
Hou X, Lu J, Weng J, Ji L, Shan Z, Liu J, Tian H, Ji Q, Zhu D, Ge J, Lin L, Chen L, Guo X, Zhao Z, Li Q, Zhou Z, Shan G, Yang Z, Yang W, Jia W; China National Diabetes and Metabolic Disorders Study Group. Hou X, et al. PLoS One. 2013;8(3):e57319. doi: 10.1371/journal.pone.0057319. Epub 2013 Mar 8. PLoS One. 2013. PMID: 23520466 Free PMC article. Clinical Trial.
175 results